Australia markets closed

StageZero Life Sciences Ltd. (SZLS.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
0.04000.0000 (0.00%)
As of 03:46PM EDT. Market open.
Currency in CAD

Valuation measures4

Market cap (intra-day) 4.91M
Enterprise value 6.72M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.12
Price/book (mrq)5.38
Enterprise value/revenue 1.72
Enterprise value/EBITDA -3.56

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 3-33.33%
S&P500 52-week change 326.36%
52-week high 30.0800
52-week low 30.0400
50-day moving average 30.0432
200-day moving average 30.0520

Share statistics

Avg vol (3-month) 348.87k
Avg vol (10-day) 3N/A
Shares outstanding 5122.72M
Implied shares outstanding 6122.72M
Float 881.54M
% held by insiders 119.99%
% held by institutions 10.00%
Shares short (30 Apr 2024) 439.71k
Short ratio (30 Apr 2024) 40.5
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.03%
Shares short (prior month 28 Mar 2024) 424.99k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Sept 2020
Ex-dividend date 4N/A
Last split factor 21:8
Last split date 318 Sept 2020

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-56.64%

Management effectiveness

Return on assets (ttm)-63.80%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)2.88M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-33.00%
Gross profit (ttm)N/A
EBITDA -4.46M
Net income avi to common (ttm)-12.53M
Diluted EPS (ttm)-0.1600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.54k
Total cash per share (mrq)0
Total debt (mrq)1.77M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.04
Book value per share (mrq)-0.07

Cash flow statement

Operating cash flow (ttm)-809.15k
Levered free cash flow (ttm)1.18M